financetom
TBI
financetom
/
Industrials
/
TBI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
TrueBlue, Inc.TBI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico.

It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company's PeopleReady segment provides general, industrial, and skilled trade staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.

Its PeopleManagement segment offers contingent, on-site industrial staffing, and commercial driver services, which includes on-site management and recruitment for the contingent industrial workforce of manufacturing, warehouse, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands.

The company's PeopleScout segment provides recruitment process outsourcing, talent advisory services, and managed service provider solutions including sourcing, screening, hiring, and onboarding services; operates Affinix, a technology platform which uses artificial intelligence and machine learning for real-time insights; and contingent labor programs including vendor selection, performance management, compliance monitoring, and risk management.

TrueBlue, Inc. was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007.

The company is headquartered in Tacoma, Washington.

Latest News >
Cargojet Renews Normal Course Issuer Bid for Voting Shares
Cargojet Renews Normal Course Issuer Bid for Voting Shares
Nov 10, 2025
05:55 AM EST, 11/10/2025 (MT Newswires) -- Cargojet ( CGJTF ) , which rose 2.5% on Friday, later that day said it has received approval from the Toronto Stock Exchange to renew its normal course issuer bid for common voting shares and variable voting shares. The NCIB is scheduled to run from Nov. 11, 2025, to Nov. 10, 2026. Purchases...
Optimism Around US Government Shutdown End, China Inflation Views Lift Asian Stock Markets
Optimism Around US Government Shutdown End, China Inflation Views Lift Asian Stock Markets
Nov 10, 2025
05:38 AM EST, 11/10/2025 (MT Newswires) -- Asian stock markets rose Monday following media reports that the US government shutdown may be nearing an end, and after relatively positive inflation reports from Beijing. Hong Kong, Shanghai and Tokyo finished in the green, as did most other regional exchanges. The South Korean KOSPI rose 3% on the US outlook, and hopes...
Monroe Capital Supports Respida Capital’s Acquisition of ENTOUCH
Monroe Capital Supports Respida Capital’s Acquisition of ENTOUCH
Nov 10, 2025
CHICAGO--(BUSINESS WIRE)-- Monroe Capital LLC (“Monroe”) announced it led the growth capital investment to support the acquisition of ENTOUCH by Respida Capital. Founded in Dallas, Texas in 2008, ENTOUCH provides energy management as a service and smart building technology. The company’s cloud-based software delivers sustainable solutions that reduce energy usage, drive profitably, and simplify facility management for multisite operators. “We...
Merck's Phase 3 Trial of Enlicitide Decanoate in Heterozygous Familial Hypercholesterolemia Achieves Primary Endpoint
Merck's Phase 3 Trial of Enlicitide Decanoate in Heterozygous Familial Hypercholesterolemia Achieves Primary Endpoint
Nov 10, 2025
05:54 AM EST, 11/10/2025 (MT Newswires) -- Merck ( MRK ) said Sunday that a phase 3 study of its elicitide decanoate product candidate achieved its primary endpoint, demonstrating statistically significant reduction in low-density lipoprotein cholesterol, or LDL-C, in adult patients with heterozygous familial hypercholesterolemia. The company said enlicitide led to a clinically meaningful LDL-C reduction of 59.4% compared with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved